{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:48:44Z","timestamp":1789850924482,"version":"4.0.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T00:00:00Z","timestamp":1248825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2334-9-119","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T18:14:27Z","timestamp":1248891267000},"source":"Crossref","is-referenced-by-count":125,"title":["Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model"],"prefix":"10.1186","volume":"9","author":[{"given":"Ralph P","family":"Insinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J","family":"Dasbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elamin H","family":"Elbasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"884_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322\/canjclin.55.2.74.","journal-title":"CA Cancer J Clin"},{"key":"884_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"key":"884_CR3","first-page":"1934","volume":"61","author":"JJ Carter","year":"2001","unstructured":"Carter JJ, Madeleine MM, Shera K, et al: Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res. 2001, 61: 1934-1940.","journal-title":"Cancer Res"},{"key":"884_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"ML Gillison","year":"2000","unstructured":"Gillison ML, Koch WM, Capone RB, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000, 92: 709-720. 10.1093\/jnci\/92.9.709.","journal-title":"J Natl Cancer Inst"},{"key":"884_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","volume":"102","author":"L Koutsky","year":"1997","unstructured":"Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med. 1997, 102: 3-8. 10.1016\/S0002-9343(97)00177-0.","journal-title":"Am J Med"},{"key":"884_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00020840-200312000-00005","volume":"11","author":"BJ Wiatrak","year":"2003","unstructured":"Wiatrak BJ: Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg. 2003, 11: 433-441. 10.1097\/00020840-200312000-00005.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"884_CR7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","volume":"96","author":"SJ Goldie","year":"2004","unstructured":"Goldie SJ, Kohli M, Grima D, et al: Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine. J Natl Cancer Inst. 2004, 96: 604-615.","journal-title":"J Natl Cancer Inst"},{"key":"884_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jama.290.6.781","volume":"290","author":"SL Kulasingam","year":"2003","unstructured":"Kulasingam SL, Myers ER: Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA. 2003, 290: 781-789. 10.1001\/jama.290.6.781.","journal-title":"JAMA"},{"key":"884_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","volume":"9","author":"GD Sanders","year":"2003","unstructured":"Sanders GD, Taira AV: Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis. 2003, 9: 37-48.","journal-title":"Emerg Infect Dis"},{"key":"884_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/epirev\/mxj006","volume":"28","author":"EJ Dasbach","year":"2006","unstructured":"Dasbach EJ, Elbasha EH, Insinga RP: Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev. 2006, 28: 88-100. 10.1093\/epirev\/mxj006.","journal-title":"Epidemiol Rev"},{"key":"884_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.281.4.347","volume":"281","author":"AD Brown","year":"1999","unstructured":"Brown AD, Garber AM: Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA. 1999, 281: 347-353. 10.1001\/jama.281.4.347.","journal-title":"JAMA"},{"key":"884_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","volume":"288","author":"SL Kulasingam","year":"2002","unstructured":"Kulasingam SL, Hughes JP, Kiviat NB, et al: Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002, 288: 1749-1757. 10.1001\/jama.288.14.1749.","journal-title":"JAMA"},{"key":"884_CR13","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.287.18.2372","volume":"287","author":"JS Mandelblatt","year":"2002","unstructured":"Mandelblatt JS, Lawrence WF, Womack SM, et al: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002, 287: 2372-2381. 10.1001\/jama.287.18.2372.","journal-title":"JAMA"},{"key":"884_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","volume":"13","author":"EH Elbasha","year":"2007","unstructured":"Elbasha EH, Dasbach EJ, Insinga RP: Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007, 13: 28-41.","journal-title":"Emerg Infect Dis"},{"key":"884_CR15","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1371\/journal.pmed.0030138","volume":"3","author":"RV Barnabas","year":"2006","unstructured":"Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP: Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses. PLoS Med. 2006, 3: e138-10.1371\/journal.pmed.0030138.","journal-title":"PLoS Med"},{"key":"884_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003, 88: 63-73. 10.1038\/sj.bjc.6600688.","journal-title":"Br J Cancer"},{"key":"884_CR17","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","volume":"37","author":"DR Brown","year":"1999","unstructured":"Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH: Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol. 1999, 37: 3316-3322.","journal-title":"J Clin Microbiol"},{"key":"884_CR18","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1128\/JCM.33.8.2058-2063.1995","volume":"33","author":"CE Greer","year":"1995","unstructured":"Greer CE, Wheeler CM, Ladner MB, et al: Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995, 33: 2058-2063.","journal-title":"J Clin Microbiol"},{"key":"884_CR19","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM, Franco EL, Wheeler C, et al: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004, 364: 1757-1765. 10.1016\/S0140-6736(04)17398-4.","journal-title":"Lancet"},{"key":"884_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL, Costa RL, Petta CA, et al: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005, 6: 271-278. 10.1016\/S1470-2045(05)70101-7.","journal-title":"Lancet Oncol"},{"key":"884_CR21","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","volume":"287","author":"JJ Kim","year":"2002","unstructured":"Kim JJ, Wright TC, Goldie SJ: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002, 287: 2382-2390. 10.1001\/jama.287.18.2382.","journal-title":"JAMA"},{"key":"884_CR22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","volume":"151","author":"ER Myers","year":"2000","unstructured":"Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB: Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000, 151: 1158-1171.","journal-title":"Am J Epidemiol"},{"key":"884_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ijc.20846","volume":"115","author":"J Berkhof","year":"2005","unstructured":"Berkhof J, de Bruijne MC, Zielinski GD, Meijer CJ: Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands. Int J Cancer. 2005, 115: 268-275. 10.1002\/ijc.20846.","journal-title":"Int J Cancer"},{"key":"884_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/sj.bjc.6602002","volume":"91","author":"K Canfell","year":"2004","unstructured":"Canfell K, Barnabas R, Patnick J, Beral V: The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. Br J Cancer. 2004, 91: 530-536. 10.1038\/sj.bjc.6602002.","journal-title":"Br J Cancer"},{"key":"884_CR25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-117-6-520","volume":"117","author":"MC Fahs","year":"1992","unstructured":"Fahs MC, Mandelblatt J, Schechter C, Muller C: Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992, 117: 520-527.","journal-title":"Ann Intern Med"},{"key":"884_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ijc.11334","volume":"106","author":"SJ Goldie","year":"2003","unstructured":"Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E: A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16\/18 vaccine. Int J Cancer. 2003, 106: 896-904. 10.1002\/ijc.11334.","journal-title":"Int J Cancer"},{"key":"884_CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000326174","volume":"49","author":"SB Cantor","year":"2005","unstructured":"Cantor SB, Atkinson EN, Cardenas-Turanzas M, Benedet JL, Follen M, MacAulay C: Natural history of cervical intraepithelial neoplasia: a meta-analysis. Acta Cytol. 2005, 49: 405-415.","journal-title":"Acta Cytol"},{"key":"884_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0029-7844(98)00245-2","volume":"92","author":"J Melnikow","year":"1998","unstructured":"Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP: Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998, 92: 727-735. 10.1016\/S0029-7844(98)00245-2.","journal-title":"Obstet Gynecol"},{"key":"884_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","volume":"12","author":"AG Ostor","year":"1993","unstructured":"Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993, 12: 186-192. 10.1097\/00004347-199304000-00018.","journal-title":"Int J Gynecol Pathol"},{"key":"884_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0028-2243(95)02303-A","volume":"65","author":"KJ Syrjanen","year":"1996","unstructured":"Syrjanen KJ: Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). Eur J Obstet Gynecol Reprod Biol. 1996, 65: 45-53. 10.1016\/0028-2243(95)02303-A.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"884_CR31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.1996.96","volume":"73","author":"CB Woodman","year":"1996","unstructured":"Woodman CB, Rollason T, Ellis J, Tierney R, Wilson S, Young L: Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix. Br J Cancer. 1996, 73: 553-556.","journal-title":"Br J Cancer"},{"key":"884_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","volume":"93","author":"D Solomon","year":"2001","unstructured":"Solomon D, Schiffman M, Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001, 93: 293-299. 10.1093\/jnci\/93.4.293.","journal-title":"J Natl Cancer Inst"},{"key":"884_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1471-0528.1996.tb09773.x","volume":"103","author":"R Chenoy","year":"1996","unstructured":"Chenoy R, Billingham L, Irani S, Rollason TP, Luesley DM, Jordan JA: The effect of directed biopsy on the atypical cervical transformation zone: assessed by digital imaging colposcopy. Br J Obstet Gynaecol. 1996, 103: 457-462.","journal-title":"Br J Obstet Gynaecol"},{"key":"884_CR34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1046\/j.1471-0528.2002.02008.x","volume":"109","author":"CB Woodman","year":"2002","unstructured":"Woodman CB, Collins S: A critique of cohort studies examining the role of human papillomavirus infection in cervical neoplasia. BJOG. 2002, 109: 1311-1318. 10.1046\/j.1471-0528.2002.02008.x.","journal-title":"BJOG"},{"key":"884_CR35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/095646249000100604","volume":"1","author":"K Syrjanen","year":"1990","unstructured":"Syrjanen K, Yliskoski M, Kataja V, et al: Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20\u201365 years. Int J STD AIDS. 1990, 1: 410-415.","journal-title":"Int J STD AIDS"},{"key":"884_CR36","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","volume":"327","author":"LA Koutsky","year":"1992","unstructured":"Koutsky LA, Holmes KK, Critchlow CW, et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992, 327: 1272-1278.","journal-title":"N Engl J Med"},{"key":"884_CR37","first-page":"1006","volume":"75","author":"GJ Nuovo","year":"1990","unstructured":"Nuovo GJ, Blanco JS, Leipzig S, Smith D: Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia. Obstet Gynecol. 1990, 75: 1006-1011.","journal-title":"Obstet Gynecol"},{"key":"884_CR38","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/jcp.52.7.498","volume":"52","author":"MV Jacobs","year":"1999","unstructured":"Jacobs MV, Snijders PJ, Voorhorst FJ, et al: Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol. 1999, 52: 498-503. 10.1136\/jcp.52.7.498.","journal-title":"J Clin Pathol"},{"key":"884_CR39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1515\/CCLM.2003.119","volume":"41","author":"S Kosel","year":"2003","unstructured":"Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B: Type-specific detection of human papillomaviruses in a routine laboratory setting \u2013 improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med. 2003, 41: 787-791. 10.1515\/CCLM.2003.119.","journal-title":"Clin Chem Lab Med"},{"key":"884_CR40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/01.AOG.0000139834.84628.61","volume":"104","author":"X Sastre-Garau","year":"2004","unstructured":"Sastre-Garau X, Cartier I, Jourdan-Da Silva N, De Cremoux P, Lepage V, Charron D: Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype. Obstet Gynecol. 2004, 104: 751-755.","journal-title":"Obstet Gynecol"},{"key":"884_CR41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1086\/427557","volume":"191","author":"RL Winer","year":"2005","unstructured":"Winer RL, Kiviat NB, Hughes JP, et al: Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis. 2005, 191: 731-738. 10.1086\/427557.","journal-title":"J Infect Dis"},{"key":"884_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1158\/1055-9965.EPI-06-0846","volume":"16","author":"RP Insinga","year":"2007","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E: Incidence and duration of cervical human papillomavirus 6, 11, 16 and 18 infections in young women: An evaluation from multiple analytic perspectives. Cancer Epidemiol Biomarkers Prev. 2007, 16: 709-715. 10.1158\/1055-9965.EPI-06-0846.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"884_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-9378-2-15","volume":"2","author":"RP Insinga","year":"2007","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E: Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer. 2007, 2: 15-10.1186\/1750-9378-2-15.","journal-title":"Infect Agent Cancer"},{"key":"884_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10198-004-0254-1","volume":"6","author":"J Holmes","year":"2005","unstructured":"Holmes J, Hemmett L, Garfield S: The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies. Eur J Health Econ. 2005, 6: 30-37. 10.1007\/s10198-004-0254-1.","journal-title":"Eur J Health Econ"},{"key":"884_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1086\/426867","volume":"191","author":"DR Brown","year":"2005","unstructured":"Brown DR, Shew ML, Qadadri B, et al: A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005, 191: 182-192. 10.1086\/426867.","journal-title":"J Infect Dis"},{"key":"884_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/341782","volume":"186","author":"AR Giuliano","year":"2002","unstructured":"Giuliano AR, Harris R, Sedjo RL, et al: Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002, 186: 462-469. 10.1086\/341782.","journal-title":"J Infect Dis"},{"key":"884_CR47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1055-9965.355.13.3","volume":"13","author":"RP Insinga","year":"2004","unstructured":"Insinga RP, Glass AG, Rush BB: Pap screening in a U.S. health plan. Cancer Epidemiol Biomarkers Prev. 2004, 13: 355-360.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"884_CR48","first-page":"5","volume":"80","author":"MS Mikhail","year":"1992","unstructured":"Mikhail MS, Merkatz IR, Romney SL: Clinical usefulness of computerized colposcopy: image analysis and conservative management of mild dysplasia. Obstet Gynecol. 1992, 80: 5-8.","journal-title":"Obstet Gynecol"},{"key":"884_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00145037","volume":"5","author":"V Kataja","year":"1989","unstructured":"Kataja V, Syrjanen K, Mantyjarvi R, et al: Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol. 1989, 5: 1-7. 10.1007\/BF00145037.","journal-title":"Eur J Epidemiol"},{"key":"884_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/aje\/kwg171","volume":"158","author":"M Molano","year":"2003","unstructured":"Molano M, Van den BA, Plummer M, et al: Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003, 158: 486-494. 10.1093\/aje\/kwg171.","journal-title":"Am J Epidemiol"},{"key":"884_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1258\/0956462053420211","volume":"16","author":"S Syrjanen","year":"2005","unstructured":"Syrjanen S, Shabalova I, Petrovichev N, et al: Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union. Int J STD AIDS. 2005, 16: 217-223. 10.1258\/0956462053420211.","journal-title":"Int J STD AIDS"},{"key":"884_CR52","first-page":"561","volume":"43","author":"R Konno","year":"1998","unstructured":"Konno R, Paez C, Sato S, Yajima A, Fukao A: HPV, histologic grade and age. Risk factors for the progression of cervical intraepithelial neoplasia. J Reprod Med. 1998, 43: 561-566.","journal-title":"J Reprod Med"},{"key":"884_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ijc.20955","volume":"116","author":"H Hoyer","year":"2005","unstructured":"Hoyer H, Scheungraber C, Kuehne-Heid R, et al: Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting. Int J Cancer. 2005, 116: 136-143. 10.1002\/ijc.20955.","journal-title":"Int J Cancer"},{"key":"884_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G","volume":"89","author":"A Schneider","year":"2000","unstructured":"Schneider A, Hoyer H, Lotz B, et al: Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer. 2000, 89: 529-534. 10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G.","journal-title":"Int J Cancer"},{"key":"884_CR55","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","volume":"357","author":"CB Woodman","year":"2001","unstructured":"Woodman CB, Collins S, Winter H, et al: Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001, 357: 1831-1836. 10.1016\/S0140-6736(00)04956-4.","journal-title":"Lancet"},{"key":"884_CR56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","volume":"107","author":"C Mao","year":"2006","unstructured":"Mao C, Koutsky LA, Ault KA, et al: Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 2006, 107: 18-27.","journal-title":"Obstet Gynecol"},{"key":"884_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1479-828X.1997.tb02230.x","volume":"37","author":"SE Furber","year":"1997","unstructured":"Furber SE, Weisberg E, Simpson JM: Progression and regression of low-grade epithelial abnormalities of the cervix. Aust N Z J Obstet Gynaecol. 1997, 37: 107-112. 10.1111\/j.1479-828X.1997.tb02230.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"884_CR58","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00019606-199812000-00006","volume":"7","author":"C Aoyama","year":"1998","unstructured":"Aoyama C, Peters J, Senadheera S, Liu P, Shimada H: Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction. Diagn Mol Pathol. 1998, 7: 324-330. 10.1097\/00019606-199812000-00006.","journal-title":"Diagn Mol Pathol"},{"key":"884_CR59","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/modpathol.3880698","volume":"15","author":"MF Evans","year":"2002","unstructured":"Evans MF, Mount SL, Beatty BG, Cooper K: Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod Pathol. 2002, 15: 1339-1347. 10.1038\/modpathol.3880698.","journal-title":"Mod Pathol"},{"key":"884_CR60","first-page":"669","volume":"56","author":"C Isacson","year":"1996","unstructured":"Isacson C, Kessis TD, Hedrick L, Cho KR: Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res. 1996, 56: 669-674.","journal-title":"Cancer Res"},{"key":"884_CR61","first-page":"1238","volume":"11","author":"BJ Quade","year":"1998","unstructured":"Quade BJ, Park JJ, Crum CP, Sun D, Dutta A: In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol. 1998, 11: 1238-1246.","journal-title":"Mod Pathol"},{"key":"884_CR62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/0046-8177(93)90117-Y","volume":"24","author":"KR Shroyer","year":"1993","unstructured":"Shroyer KR, Lovelace GS, Abarca ML, et al: Detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction in human papillomavirus equivocal and dysplastic cervical biopsies. Hum Pathol. 1993, 24: 1012-1016. 10.1016\/0046-8177(93)90117-Y.","journal-title":"Hum Pathol"},{"key":"884_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/sj.clpt.6100055","volume":"81","author":"L Shi","year":"2007","unstructured":"Shi L, Sings HL, Bryan JT, et al: GARDASIL: prophylactic human papillomavirus vaccine development \u2013 from bench top to bed-side. Clin Pharmacol Ther. 2007, 81: 259-264. 10.1038\/sj.clpt.6100055.","journal-title":"Clin Pharmacol Ther"},{"key":"884_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-527. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"key":"884_CR65","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3109\/00016349409006256","volume":"73","author":"D De Aloysio","year":"1994","unstructured":"De Aloysio D, Miliffi L, Iannicelli T, Penacchioni P, Bottiglioni F: Intramuscular interferon-beta treatment of cervical intraepithelial neoplasia II associated with human papillomavirus infection. Acta Obstet Gynecol Scand. 1994, 73: 420-424. 10.3109\/00016349409006256.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"884_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000, 70: 209-262. 10.1016\/S0020-7292(00)90001-8.","journal-title":"Int J Gynaecol Obstet"},{"key":"884_CR67","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/978-1-4899-0036-4_33","volume-title":"Viral Infections of Humans","author":"M Schiffman","year":"1997","unstructured":"Schiffman M, Burk R: Human Papillomaviruses. Viral Infections of Humans. Edited by: Evans A, Kaslow R. 1997, New York, NY: Plenum Publishing Co, 983-1023. 4","edition":"4"},{"key":"884_CR68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/00016348109155484","volume":"60","author":"L Westergaard","year":"1981","unstructured":"Westergaard L, Norgaard M: Severe cervical dysplasia. Control by biopsies or primary conization? A comparative study. Acta Obstet Gynecol Scand. 1981, 60: 549-554.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"884_CR69","unstructured":"SEER*Stat 6.1.4 \u2013 SEER Cancer Incidence Public-Use Database, 1973\u20132002. 4-25-0005. Bethesda, MD, U.S.A., Cancer Statistics Branch, National Cancer Institute, National Insititutes of Health"},{"key":"884_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#","volume":"71","author":"L Gustafsson","year":"1997","unstructured":"Gustafsson L, Ponten J, Bergstrom R, Adami HO: International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer. 1997, 71: 159-165. 10.1002\/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#.","journal-title":"Int J Cancer"},{"key":"884_CR71","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1086\/428850","volume":"191","author":"R Herrero","year":"2005","unstructured":"Herrero R, Castle PE, Schiffman M, et al: Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005, 191: 1796-1807. 10.1086\/428850.","journal-title":"J Infect Dis"},{"key":"884_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1363\/3601104","volume":"36","author":"HW Chesson","year":"2004","unstructured":"Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL: The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004, 36: 11-19. 10.1363\/3601104.","journal-title":"Perspect Sex Reprod Health"},{"key":"884_CR73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","volume":"191","author":"RP Insinga","year":"2004","unstructured":"Insinga RP, Glass AG, Rush BB: Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004, 191: 105-113. 10.1016\/j.ajog.2004.01.043.","journal-title":"Am J Obstet Gynecol"},{"key":"884_CR74","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10552-004-6295-z","volume":"16","author":"JF Nygard","year":"2005","unstructured":"Nygard JF, Nygard M, Skare GB, Thoresen SO: Screening histories of women with CIN 2\/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program. Cancer Causes Control. 2005, 16: 463-474. 10.1007\/s10552-004-6295-z.","journal-title":"Cancer Causes Control"},{"key":"884_CR75","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jnci\/57.5.1037","volume":"57","author":"PW Laskey","year":"1976","unstructured":"Laskey PW, Meigs JW, Flannery JT: Uterine cervical carcinoma in Connecticut, 1935\u20131973: evidence for two classes of invasive disease. J Natl Cancer Inst. 1976, 57: 1037-1043.","journal-title":"J Natl Cancer Inst"},{"key":"884_CR76","first-page":"1","volume":"73","author":"HF Dorn","year":"1959","unstructured":"Dorn HF, Cutler SJ: Morbidity from cancer in the United States. Public Health Monogr. 1959, 73: 1-207.","journal-title":"Public Health Monogr"},{"key":"884_CR77","first-page":"173","volume":"12","author":"II Kessler","year":"1974","unstructured":"Kessler II: Cervical cancer epidemiology in historical perspective. J Reprod Med. 1974, 12: 173-185.","journal-title":"J Reprod Med"},{"key":"884_CR78","first-page":"373","volume":"24","author":"MF Evans","year":"2003","unstructured":"Evans MF, Mount SL, Vacek PM, Cooper K: High-risk human papillomavirus type does not predict grade of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 2003, 24: 373-376.","journal-title":"Eur J Gynaecol Oncol"},{"key":"884_CR79","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1053\/hupa.2003.40","volume":"34","author":"MH Oktay","year":"2003","unstructured":"Oktay MH, Oktay K, Hamele-Bena D, Buyuk A, Koss LG: Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol. 2003, 34: 240-245. 10.1053\/hupa.2003.40.","journal-title":"Hum Pathol"},{"key":"884_CR80","first-page":"485","volume":"12","author":"H Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P, et al: The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2003, 12: 485-490.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"884_CR81","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","volume":"24","author":"LL Villa","year":"2006","unstructured":"Villa LL, Ault KA, Giuliano AR, et al: Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 2006, 24: 5571-5583. 10.1016\/j.vaccine.2006.04.068.","journal-title":"Vaccine"},{"key":"884_CR82","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky LA, Ault KA, Wheeler CM, et al: A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002, 347: 1645-1651. 10.1056\/NEJMoa020586.","journal-title":"N Engl J Med"},{"key":"884_CR83","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","volume":"13","author":"RP Viscidi","year":"2004","unstructured":"Viscidi RP, Schiffman M, Hildesheim A, et al: Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2004, 13: 324-327. 10.1158\/1055-9965.EPI-03-0166.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"884_CR84","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1086\/517428","volume":"177","author":"G af V","year":"1998","unstructured":"af G, Kibur M, Wang Z, et al: Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis. 1998, 177: 1710-1714. 10.1086\/517428.","journal-title":"J Infect Dis"},{"key":"884_CR85","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canlet.2005.02.023","volume":"231","author":"K Matsumoto","year":"2006","unstructured":"Matsumoto K, Yasugi T, Oki A, et al: IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia. Cancer Lett. 2006, 231: 309-313. 10.1016\/j.canlet.2005.02.023.","journal-title":"Cancer Lett"},{"issue":"Suppl 1","key":"884_CR86","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1086\/514722","volume":"28","author":"KR Beutner","year":"1999","unstructured":"Beutner KR, Wiley DJ, Douglas JM, et al: Genital warts and their treatment. Clin Infect Dis. 1999, 28 (Suppl 1): S37-S56. 10.1086\/514722.","journal-title":"Clin Infect Dis"},{"key":"884_CR87","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1086\/342109","volume":"35","author":"DJ Wiley","year":"2002","unstructured":"Wiley DJ, Douglas J, Beutner K, et al: External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002, 35: S210-S224. 10.1086\/342109.","journal-title":"Clin Infect Dis"},{"key":"884_CR88","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/0002-9378(95)90404-2","volume":"172","author":"A Friedman-Kien","year":"1995","unstructured":"Friedman-Kien A: Management of condylomata acuminata with Alferon N injection, interferon alfa-n3 (human leukocyte derived). Am J Obstet Gynecol. 1995, 172: 1359-1368. 10.1016\/0002-9378(95)90404-2.","journal-title":"Am J Obstet Gynecol"},{"key":"884_CR89","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1258\/095646203322387983","volume":"14","author":"GM Wildman","year":"2003","unstructured":"Wildman GM, Tang A: Have a nice day \u2013 do a wart audit. Int J STD AIDS. 2003, 14: 710-711. 10.1258\/095646203322387983.","journal-title":"Int J STD AIDS"},{"key":"884_CR90","volume-title":"SEER cancer statistics review, 1975\u20132002","author":"L Ries","year":"2005","unstructured":"Ries L, Eisner M, Kosary C, et al: SEER cancer statistics review, 1975\u20132002. 2005, Bethesda, MD, National Cancer Institute, [ http:\/\/seer.cancer.gov\/csr\/1975_2002\/ ]"},{"key":"884_CR91","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/gyno.1999.5364","volume":"73","author":"RJ Chen","year":"1999","unstructured":"Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY: Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol. 1999, 73: 184-190. 10.1006\/gyno.1999.5364.","journal-title":"Gynecol Oncol"},{"key":"884_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0020-7292(01)00471-4","volume":"75","author":"L Flores-Luna","year":"2001","unstructured":"Flores-Luna L, Salazar-Martinez E, Escudero-De los RP, Gonzalez-Lira G, Zamora-Munoz S, Lazcano-Ponce E: Prognostic factors related to cervical cancer survival in Mexican women. Int J Gynaecol Obstet. 2001, 75: 33-42. 10.1016\/S0020-7292(01)00471-4.","journal-title":"Int J Gynaecol Obstet"},{"key":"884_CR93","first-page":"1","volume":"51","author":"H Keshavarz","year":"2002","unstructured":"Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA: Hysterectomy surveillance-United States, 1994\u20131999. MMWR CDC Surveill Summ. 2002, 51: 1-8.","journal-title":"MMWR CDC Surveill Summ"},{"key":"884_CR94","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0306-5456(00)00098-X","volume":"108","author":"JC Redburn","year":"2001","unstructured":"Redburn JC, Murphy MF: Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales. BJOG. 2001, 108: 388-395. 10.1016\/S0306-5456(00)00098-X.","journal-title":"BJOG"},{"key":"884_CR95","unstructured":"Analysis of women's health care utilization in Taiwan \u2013 cesaerean section, hysterectomy, service-specific and group specific utilization rate.: Final report. 2004, Taipei: Department of Health, Bureau of National Health Insurance"},{"key":"884_CR96","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/016327879702000305","volume":"20","author":"JB Fowles","year":"1997","unstructured":"Fowles JB, Fowler E, Craft C, McCoy CE: Comparing claims data and self-reported data with the medical record for Pap smear rates. Eval Health Prof. 1997, 20: 324-342. 10.1177\/016327879702000305.","journal-title":"Eval Health Prof"},{"key":"884_CR97","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/jnci\/85.7.566","volume":"85","author":"NP Gordon","year":"1993","unstructured":"Gordon NP, Hiatt RA, Lampert DI: Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993, 85: 566-570. 10.1093\/jnci\/85.7.566.","journal-title":"J Natl Cancer Inst"},{"key":"884_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0749-3797(97)00076-7","volume":"14","author":"PG McGovern","year":"1998","unstructured":"McGovern PG, Lurie N, Margolis KL, Slater JS: Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med. 1998, 14: 201-208. 10.1016\/S0749-3797(97)00076-7.","journal-title":"Am J Prev Med"},{"key":"884_CR99","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2105\/AJPH.90.9.1431","volume":"90","author":"S Newell","year":"2000","unstructured":"Newell S, Girgis A, Sanson-Fisher R, Ireland M: Accuracy of patients' recall of Pap and cholesterol screening. Am J Public Health. 2000, 90: 1431-1435. 10.2105\/AJPH.90.9.1431.","journal-title":"Am J Public Health"},{"key":"884_CR100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0749-3797(18)30483-5","volume":"11","author":"L Suarez","year":"1995","unstructured":"Suarez L, Goldman DA, Weiss NS: Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med. 1995, 11: 94-98.","journal-title":"Am J Prev Med"},{"key":"884_CR101","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00005650-199907000-00006","volume":"37","author":"DB Wallihan","year":"1999","unstructured":"Wallihan DB, Stump TE, Callahan CM: Accuracy of self-reported health services use and patterns of care among urban older adults. Med Care. 1999, 37: 662-670. 10.1097\/00005650-199907000-00006.","journal-title":"Med Care"},{"key":"884_CR102","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.healthpol.2004.11.012","volume":"73","author":"SK Chattopadhyay","year":"2005","unstructured":"Chattopadhyay SK, Ebrahim SH, Tao G, McKenna MT: Use of cervical cancer screening among insured women: the extent of missed opportunities. Health Policy. 2005, 73: 194-201. 10.1016\/j.healthpol.2004.11.012.","journal-title":"Health Policy"},{"key":"884_CR103","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1525-1497.2004.21107.x","volume":"19","author":"BE Sirovich","year":"2004","unstructured":"Sirovich BE, Welch HG: The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004, 19: 243-250. 10.1111\/j.1525-1497.2004.21107.x.","journal-title":"J Gen Intern Med"},{"key":"884_CR104","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2105\/AJPH.85.6.791","volume":"85","author":"DT Janerich","year":"1995","unstructured":"Janerich DT, Hadjimichael O, Schwartz PE, et al: The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995, 85: 791-794. 10.2105\/AJPH.85.6.791.","journal-title":"Am J Public Health"},{"key":"884_CR105","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.0.CO;2-D","volume":"88","author":"HY Sung","year":"2000","unstructured":"Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA: Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000, 88: 2283-2289. 10.1002\/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.0.CO;2-D.","journal-title":"Cancer"},{"key":"884_CR106","volume-title":"Health Policy","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Glass AG, Rush BB: Response to \"Use of cervical cancer screening among insured women: the extent of missed opportunities\" [Health Policy 73 (2005) 194\u2013201]. Health Policy. 2005"},{"key":"884_CR107","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/oxfordjournals.aje.a009226","volume":"146","author":"RB Warnecke","year":"1997","unstructured":"Warnecke RB, Sudman S, Johnson TP, O'Rourke D, Davis AM, Jobe JB: Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms. Am J Epidemiol. 1997, 146: 982-992.","journal-title":"Am J Epidemiol"},{"key":"884_CR108","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ypmed.2004.03.035","volume":"39","author":"M Hewitt","year":"2004","unstructured":"Hewitt M, Devesa SS, Breen N: Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med. 2004, 39: 270-278. 10.1016\/j.ypmed.2004.03.035.","journal-title":"Prev Med"},{"key":"884_CR109","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/jech.2005.041020","volume":"60","author":"M Schootman","year":"2006","unstructured":"Schootman M, Jeffe DB, Baker EA, Walker MS: Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006, 60: 202-207. 10.1136\/jech.2005.041020.","journal-title":"J Epidemiol Community Health"},{"key":"884_CR110","volume-title":"National Health Service Cervical Screening Programme Statistics. Leeds, United Kingdom","author":"Cervical cancer screening program [2005\/2006]","year":"2007","unstructured":"Cervical cancer screening program [2005\/2006]: National Health Service Cervical Screening Programme Statistics. Leeds, United Kingdom. 2007, [ http:\/\/www.ic.nhs.uk\/pubs\/csp0506 ]"},{"key":"884_CR111","unstructured":"Taiwan Pap Registry Annual Report, 2005: 2005, Bureau of Health Promotion, Department of Health, ROC"},{"key":"884_CR112","volume-title":"Avances del programa de detecci\u00f3n oportuna del c\u00e1ncer cervical en M\u00e9xico","author":"M Louftalot","year":"2005","unstructured":"Louftalot M: Avances del programa de detecci\u00f3n oportuna del c\u00e1ncer cervical en M\u00e9xico. 2005, Presented at the XI Congreso de Investigaci\u00f3n en Salud P\u00fablica, Cuernavaca, Mexico"},{"key":"884_CR113","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ajog.2004.09.026","volume":"192","author":"M Saint","year":"2005","unstructured":"Saint M, Gildengorin G, Sawaya GF: Current cervical neoplasia screening practices of obstetrician\/gynecologists in the US. Am J Obstet Gynecol. 2005, 192: 414-421. 10.1016\/j.ajog.2004.09.026.","journal-title":"Am J Obstet Gynecol"},{"key":"884_CR114","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bjc.6602728","volume":"93","author":"G Bigras","year":"2005","unstructured":"Bigras G, de Marval F: The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer. 2005, 93: 575-581. 10.1038\/sj.bjc.6602728.","journal-title":"Br J Cancer"},{"key":"884_CR115","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/bmj.326.7392.733","volume":"326","author":"J Coste","year":"2003","unstructured":"Coste J, Cochand-Priollet B, De Cremoux P, et al: Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ. 2003, 326: 733-10.1136\/bmj.326.7392.733.","journal-title":"BMJ"},{"key":"884_CR116","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/dc.1091","volume":"24","author":"B Cochand-Priollet","year":"2001","unstructured":"Cochand-Priollet B, Le Gales C, De Cremoux P, et al: Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: protocol of the study of the French Society of Clinical Cytology. Diagn Cytopathol. 2001, 24: 412-420. 10.1002\/dc.1091.","journal-title":"Diagn Cytopathol"},{"key":"884_CR117","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0029-7844(98)00006-4","volume":"91","author":"MF Mitchell","year":"1998","unstructured":"Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R: Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998, 91: 626-631. 10.1016\/S0029-7844(98)00006-4.","journal-title":"Obstet Gynecol"},{"key":"884_CR118","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(SICI)1098-0997(1998)6:5<214::AID-IDOG5>3.0.CO;2-I","volume":"6","author":"AL Distefano","year":"1998","unstructured":"Distefano AL, Picconi MA, Alonio LV, et al: Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision. Infect Dis Obstet Gynecol. 1998, 6: 214-219. 10.1002\/(SICI)1098-0997(1998)6:5<214::AID-IDOG5>3.0.CO;2-I.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"884_CR119","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1997.tb11983.x","volume":"104","author":"G Flannelly","year":"1997","unstructured":"Flannelly G, Langhan H, Jandial L, Mana E, Campbell M, Kitchener H: A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1997, 104: 718-722.","journal-title":"Br J Obstet Gynaecol"},{"key":"884_CR120","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1136\/bmj.300.6741.1690","volume":"300","author":"DM Luesley","year":"1990","unstructured":"Luesley DM, Cullimore J, Redman CW, et al: Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ. 1990, 300: 1690-1693. 10.1136\/bmj.300.6741.1690.","journal-title":"BMJ"},{"key":"884_CR121","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1471-0528.1992.tb13704.x","volume":"99","author":"JB Murdoch","year":"1992","unstructured":"Murdoch JB, Morgan PR, Lopes A, Monaghan JM: Histological incomplete excision of CIN after large loop excision of the transformation zone (LLETZ) merits careful follow up, not retreatment. Br J Obstet Gynaecol. 1992, 99: 990-993.","journal-title":"Br J Obstet Gynaecol"},{"key":"884_CR122","first-page":"196","volume":"93","author":"RJ Chen","year":"1994","unstructured":"Chen RJ, Chang DY, Yen ML, Chow SN, Huang SC: Loop electrosurgical excision procedure for conization of the uterine cervix. J Formos Med Assoc. 1994, 93: 196-199.","journal-title":"J Formos Med Assoc"},{"key":"884_CR123","first-page":"257","volume":"15","author":"BA Goff","year":"1994","unstructured":"Goff BA, Rice LW, Fleischhacker DS, Abu-Jawdeh GM, Muntz HG: Large loop excision of the transformation zone in patients with exocervical squamous intraepithelial lesions. Eur J Gynaecol Oncol. 1994, 15: 257-262.","journal-title":"Eur J Gynaecol Oncol"},{"key":"884_CR124","first-page":"173","volume":"79","author":"TC Wright Jr","year":"1992","unstructured":"Wright TC, Gagnon S, Richart RM, Ferenczy A: Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure. Obstet Gynecol. 1992, 79: 173-178.","journal-title":"Obstet Gynecol"},{"key":"884_CR125","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ijc.10691","volume":"102","author":"RL Bekkers","year":"2002","unstructured":"Bekkers RL, Melchers WJ, Bakkers JM, et al: The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia. Int J Cancer. 2002, 102: 148-151. 10.1002\/ijc.10691.","journal-title":"Int J Cancer"},{"key":"884_CR126","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0029-7844(96)00505-4","volume":"89","author":"F Gardeil","year":"1997","unstructured":"Gardeil F, Barry-Walsh C, Prendiville W, Clinch J, Turner MJ: Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol. 1997, 89: 419-422. 10.1016\/S0029-7844(96)00505-4.","journal-title":"Obstet Gynecol"},{"key":"884_CR127","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1471-0528.2002.01554.x","volume":"109","author":"ME Cruickshank","year":"2002","unstructured":"Cruickshank ME, Sharp L, Chambers G, Smart L, Murray G: Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. BJOG. 2002, 109: 579-581. 10.1111\/j.1471-0528.2002.01554.x.","journal-title":"BJOG"},{"key":"884_CR128","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ctrv.2003.07.008","volume":"30","author":"E Paraskevaidis","year":"2004","unstructured":"Paraskevaidis E, Arbyn M, Sotiriadis A, et al: The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev. 2004, 30: 205-211. 10.1016\/j.ctrv.2003.07.008.","journal-title":"Cancer Treat Rev"},{"key":"884_CR129","first-page":"375","volume":"12","author":"J Fen","year":"2004","unstructured":"Fen J, Yoshinouchi M, Nakamura K, et al: Eradication of HPV post-surgical treatments, its correlation with specific types, types of surgery and the physical status. Oncol Rep. 2004, 12: 375-379.","journal-title":"Oncol Rep"},{"key":"884_CR130","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00000441-199507000-00006","volume":"310","author":"I Arany","year":"1995","unstructured":"Arany I, Rady P, Tyring SK: Effect of interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum. Am J Med Sci. 1995, 310: 14-18. 10.1097\/00000441-199507000-00006.","journal-title":"Am J Med Sci"},{"key":"884_CR131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1346-8138.1998.tb02429.x","volume":"25","author":"TA Syed","year":"1998","unstructured":"Syed TA, Ahmadpour OA, Ahmad SA, Ahmad SH: Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study. J Dermatol. 1998, 25: 429-433.","journal-title":"J Dermatol"},{"key":"884_CR132","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1258\/095646204323012797","volume":"15","author":"FM Carey","year":"2004","unstructured":"Carey FM, Quah SP, Dinsmore W, Maw RD: Patient assessment of anogenital warts and the success of treatment with home applied therapy. Int J STD AIDS. 2004, 15: 316-318. 10.1258\/095646204323012797.","journal-title":"Int J STD AIDS"},{"key":"884_CR133","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1086\/340743","volume":"35","author":"DJ Wiley","year":"2002","unstructured":"Wiley DJ, Grosser S, Qi K, et al: Validity of self-reporting of episodes of external genital warts. Clin Infect Dis. 2002, 35: 39-45. 10.1086\/340743.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-9-119\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T05:25:01Z","timestamp":1685078701000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-9-119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-9-119","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]},"article-number":"119"}}